Incidence, trend and risk factors associated with suicide among patients with malignant intracranial tumors: a surveillance, epidemiology, and end results analysis

被引:0
作者
Zhihuan Zhou
Pingping Jiang
Peiyu Zhang
Xiaoping Lin
Qinqin Zhao
Xia Wen
Xiaoyan Lin
Yueli Wang
Yu Yang
Xiaobing Jiang
Zhongping Chen
Yonggao Mou
Depei Li
Ke Sai
机构
[1] Sun Yat-Sen University Cancer Center,Department of Neurosurgery/Neuro
[2] Sun Yat-Sen University Cancer Center,Oncology
[3] The First Affiliated Hospital of Guangdong Pharmaceutical University,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[4] Sun Yat-Sen University Cancer Center,Department of Traditional Chinese Medicine
来源
International Journal of Clinical Oncology | 2022年 / 27卷
关键词
Malignant intracranial tumors; Glioblastoma; Suicide; Risk factors; SEER;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1386 / 1393
页数:7
相关论文
共 77 条
[1]  
Fazel S(2020)Suicide N Engl J Med 382 266-274
[2]  
Runeson B(2019)Suicide among cancer patients Nat Commun 10 207-4738
[3]  
Zaorsky NG(2008)Incidence of suicide in persons with cancer J Clin Oncol 26 4731-996
[4]  
Zhang Y(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-432
[5]  
Tuanquin L(2013)Suicide ideation in pediatric and adult survivors of childhood brain tumors J Neurooncol 113 425-1121
[6]  
Misono S(2020)Association of brain cancer with risk of suicide JAMA Netw Open 3 1117-1414
[7]  
Weiss NS(1999)The surveillance, epidemiology, and end results program: a national resource Cancer Epidemiol Biomarkers Prev 8 1396-3779
[8]  
Fann JR(2019)Trends in incidence and survival in patients with melanoma, 1974–2013 Am J Cancer Res 9 3767-997
[9]  
Stupp R(2020)Trend and socioeconomic disparities in survival outcome of metastatic melanoma after approval of immune checkpoint inhibitors: a population-based study Am J Transl Res 12 992-648
[10]  
Mason WP(2017)Making the case for investment in rural cancer control: an analysis of rural cancer incidence, mortality, and funding trends Cancer Epidemiol Biomarkers Prev 26 640-198